Tumor - Brain Metastases: Integrating Stereotactic Radiotherapy with Immunotherapy and Targeted Therapy episode artwork

EPISODE · Apr 12, 2026 · 4 MIN

Tumor - Brain Metastases: Integrating Stereotactic Radiotherapy with Immunotherapy and Targeted Therapy

from Neurosurgery Hub Podcast · host Neurosurgery Hub Team

This episode delves into the critical interplay between advanced systemic therapies and local treatment for brain metastases. Based on the abstract of a study published in Clinical Oncology in 2026, we explore the efficacy and safety of combining stereotactic radiotherapy, specifically using the CyberKnife system, with immunotherapy or targeted therapy in patients with brain metastases from advanced solid cancers. The discussion highlights key findings regarding local control and overall efficacy, providing valuable insights into optimizing treatment strategies for this challenging patient population. Understanding these combined treatment approaches is essential for improving outcomes and managing intracranial disease. This podcast is for informational purposes and does not constitute medical advice.

Episode metadata supplied by the publisher feed · Published Apr 12, 2026

Embed this episode

NOW PLAYING

Tumor - Brain Metastases: Integrating Stereotactic Radiotherapy with Immunotherapy and Targeted Therapy

0:00 4:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurosurgery Hub Podcast?

This episode is 4 minutes long.

When was this Neurosurgery Hub Podcast episode published?

This episode was published on April 12, 2026.

Can I download this Neurosurgery Hub Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!